Cargando…

Melanoma incidence and mortality in Scotland 1979–2003

We studied 12 450 cases of invasive melanoma diagnosed in Scotland in 1979–2003, by thickness, pathological type, and body site at ages under 40, 40–59, and 60 years and over. Melanoma incidence trebled in males from 3.57 to 10.93/10(5) per year, and increased 2.3-fold in females from 5.60 to 12.96/...

Descripción completa

Detalles Bibliográficos
Autores principales: MacKie, R M, Bray, C, Vestey, J, Doherty, V, Evans, A, Thomson, D, Nicolson, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359933/
https://www.ncbi.nlm.nih.gov/pubmed/17533392
http://dx.doi.org/10.1038/sj.bjc.6603801
_version_ 1782152923267989504
author MacKie, R M
Bray, C
Vestey, J
Doherty, V
Evans, A
Thomson, D
Nicolson, M
author_facet MacKie, R M
Bray, C
Vestey, J
Doherty, V
Evans, A
Thomson, D
Nicolson, M
author_sort MacKie, R M
collection PubMed
description We studied 12 450 cases of invasive melanoma diagnosed in Scotland in 1979–2003, by thickness, pathological type, and body site at ages under 40, 40–59, and 60 years and over. Melanoma incidence trebled in males from 3.57 to 10.93/10(5) per year, and increased 2.3-fold in females from 5.60 to 12.96/10(5) per year. The rate of increase fell in each successive 5-year period. The greatest increase was in males aged 60 years and over at diagnosis. Significant incidence increases were seen in melanomas <1 mm in all three age groups, but those >4 mm only increased significantly at ages 60 years and over. All histological types increased significantly at ages 60 years and over, and in this age group the greatest increase was seen on the head and neck. Five-year disease-free survival improved steadily. Survival figures for 1994–1998 ranged from 93.6% for males and 95.8% for females with tumours <1 mm, to 52.4 and 48.3%, respectively, for those with tumours >4 mm. Over the 25 years, melanoma mortality doubled in males from 1.1 to 2.4/10(5) per year, but was unchanged in females at 1.5/10(5) per year. Public education on melanoma is required both for primary prevention and earlier diagnosis, particularly for older males.
format Text
id pubmed-2359933
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23599332009-09-10 Melanoma incidence and mortality in Scotland 1979–2003 MacKie, R M Bray, C Vestey, J Doherty, V Evans, A Thomson, D Nicolson, M Br J Cancer Epidemiology We studied 12 450 cases of invasive melanoma diagnosed in Scotland in 1979–2003, by thickness, pathological type, and body site at ages under 40, 40–59, and 60 years and over. Melanoma incidence trebled in males from 3.57 to 10.93/10(5) per year, and increased 2.3-fold in females from 5.60 to 12.96/10(5) per year. The rate of increase fell in each successive 5-year period. The greatest increase was in males aged 60 years and over at diagnosis. Significant incidence increases were seen in melanomas <1 mm in all three age groups, but those >4 mm only increased significantly at ages 60 years and over. All histological types increased significantly at ages 60 years and over, and in this age group the greatest increase was seen on the head and neck. Five-year disease-free survival improved steadily. Survival figures for 1994–1998 ranged from 93.6% for males and 95.8% for females with tumours <1 mm, to 52.4 and 48.3%, respectively, for those with tumours >4 mm. Over the 25 years, melanoma mortality doubled in males from 1.1 to 2.4/10(5) per year, but was unchanged in females at 1.5/10(5) per year. Public education on melanoma is required both for primary prevention and earlier diagnosis, particularly for older males. Nature Publishing Group 2007-06-04 2007-05-29 /pmc/articles/PMC2359933/ /pubmed/17533392 http://dx.doi.org/10.1038/sj.bjc.6603801 Text en Copyright © 2007 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
MacKie, R M
Bray, C
Vestey, J
Doherty, V
Evans, A
Thomson, D
Nicolson, M
Melanoma incidence and mortality in Scotland 1979–2003
title Melanoma incidence and mortality in Scotland 1979–2003
title_full Melanoma incidence and mortality in Scotland 1979–2003
title_fullStr Melanoma incidence and mortality in Scotland 1979–2003
title_full_unstemmed Melanoma incidence and mortality in Scotland 1979–2003
title_short Melanoma incidence and mortality in Scotland 1979–2003
title_sort melanoma incidence and mortality in scotland 1979–2003
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359933/
https://www.ncbi.nlm.nih.gov/pubmed/17533392
http://dx.doi.org/10.1038/sj.bjc.6603801
work_keys_str_mv AT mackierm melanomaincidenceandmortalityinscotland19792003
AT brayc melanomaincidenceandmortalityinscotland19792003
AT vesteyj melanomaincidenceandmortalityinscotland19792003
AT dohertyv melanomaincidenceandmortalityinscotland19792003
AT evansa melanomaincidenceandmortalityinscotland19792003
AT thomsond melanomaincidenceandmortalityinscotland19792003
AT nicolsonm melanomaincidenceandmortalityinscotland19792003
AT melanomaincidenceandmortalityinscotland19792003